Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice
- 13 February 2007
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 205 (1), 166-176
- https://doi.org/10.1016/j.expneurol.2007.01.037
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patientsPsychiatry and Clinical Neurosciences, 2005
- Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2005
- Effect of LTP-reinforcing paradigms on neurotransmitter release in the dentate gyrus of young and aged ratsBiochemical and Biophysical Research Communications, 2004
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNFAgeing Research Reviews, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Alzheimer's disease: From molecular biology to neuropsychiatrySeminars in Clinical Neuropsychiatry, 2003
- GABA-A and 5-HT1A Receptor Agonists Block Expression of Fear-Potentiated Startle in MiceNeuropsychopharmacology, 2002
- Relative Roles of Plaques and Tangles in the Dementia of Alzheimer's Disease: Correlations Using Three Sets of Neuropathological CriteriaDementia and Geriatric Cognitive Disorders, 1995
- Emotional Memory: In Search of Systems and SynapsesaAnnals of the New York Academy of Sciences, 1993